Key result
Thoracoscopic epicardial LV lead implantation yields 100% procedural success with no major complications.
Why the study?
Epicardial placement of the LV lead is an alternative to standard CRT, but long-term safety and effectiveness of a minimally invasive thoracoscopic technique needed evaluation.
Does a minimally invasive thoracoscopic technique provide safe and effective epicardial LV lead implantation in patients with failed transvenous approaches or lead dislodgment?
Observational (n=89)
No
Does a minimally invasive thoracoscopic technique provide safe and effective epicardial LV lead implantation in patients with failed transvenous approaches or lead dislodgment?
A minimally invasive thoracoscopic approach for epicardial LV lead implantation is a safe and effective alternative for patients with failed transvenous implantation or lead dislodgment.
Answers are grounded in this paper and cite their sources.
May support thoracoscopic epicardial LV leads after transvenous failure; hypothesis-generating and requires randomized trials before practice change.
Background: Epicardial placement of the left ventricular (LV) lead is an alternative approach to the standard cardiac resynchronization therapy (CRT) procedure. In our center we developed a minimally invasive thoracoscopic technique. We reviewed our experience to evaluate the long-term safety and effectiveness of the technique. Methods: The procedure is performed under general anesthesia with oro-tracheal intubation and right-sided ventilation, and requires 3 thoracoscopic ports (two 5-mm and one 15-mm). We analyzed 94 consecutive patients referred to our center for epicardial LV lead implantation. Results: Five patients were excluded because of concomitant conditions precluding surgery or lack of indication for CRT. The remaining 89 patients underwent the procedure. Of these, 57 had undergone previous unsuccessful LV lead implantation (Group 1). In the remaining 32 patients, effective CRT was discontinued owing to LV lead dislodgment (Group 2). LV lead implantation was successful in all patients (median pacing threshold 0.8V, IQR: 0.6-1.2, at 0.5 ms, no phrenic nerve stimulation) and CRT was successfully established in all but one patient. No complications were reported, except for 2 cases of transitory peri-electrode bleeding and 3 cases of ventricular fibrillation induced during the procedure (no sequelae). The median procedure time was 75 min (IQR: 55-95). During a median follow-up of 24 [IQR: 13-39] months, 21 patients died and 4 additional device-related complications were reported (comparable rates between groups). Conclusions: Our thoracoscopic approach proved to be safe and effective. It is a viable alternative to the standard transvenous approach in the case of failed de novo implantation and in those patients who positively respond to CRT but experience LV lead dislodgment.
No takes yet. Share an insight, caveat, or question.
Droghetti et al. (2018) conducted an observational in Heart failure requiring cardiac resynchronization therapy (n=89). Minimally invasive thoracoscopic technique for epicardial LV lead implantation was evaluated on Successful LV lead implantation. A minimally invasive thoracoscopic technique for epicardial LV lead implantation was successful in 100% of patients, with CRT established in all but one patient and no major complications.
Synapse has enriched 10 related papers. Consider them for comparative context: